This is a vaccine-mechanism module, not a specific disease. Disorder entries for encapsulated bacteria reference the pathogen-side target node via conforms_to ("polysaccharide_conjugate_t_dependent_switching#Polysaccharide Capsule-Mediated Mucosal Colonization and Complement Evasion"), and their glycoconjugate vaccine treatments point at that conforming node via target_mechanisms.
Carrier Protein MHC Class II Presentation and Cognate T-B Cell Help
trigger
Unconjugated bacterial capsular polysaccharides behave as T-cell-independent antigens that crosslink B-cell receptors without MHC class II peptide presentation, yielding predominantly low-affinity IgM responses with poor immunogenicity in infants and no immunological memory. Covalent linkage of the capsular polysaccharide to a carrier protein enables polysaccharide-specific B cells to bind the carbohydrate epitope, internalize the entire glycoconjugate, and present carrier-derived peptides on MHC class II molecules to cognate CD4+ T helper cells.
Downstream
-
Germinal Center Isotype Switching, Affinity Maturation, and B-Cell Memory
Cognate CD4+ T helper cells drive germinal center class-switch recombination from IgM to high-affinity IgG and differentiation of long-lived memory B cells
Show evidence (2 references)
"Polysaccharides are T-cell-independent antigens which lead primarily to IgM responses with little isotype switching to IgG antibody"
Establishes that unconjugated bacterial capsular polysaccharides act as T-cell-independent antigens that elicit predominantly IgM without class switching to IgG.
"To address the reduced immunogenicity of polysaccharide vaccines in infants, conjugated protein-polysaccharide (glycoconjugate) vaccines were developed"
Demonstrates the rationale for covalent protein-polysaccharide conjugation to overcome infant hyporesponsiveness to plain polysaccharide antigens.
Germinal Center Isotype Switching, Affinity Maturation, and B-Cell Memory
amplifier
Activated carrier-specific CD4+ T helper cells provide costimulatory and cytokine signals to polysaccharide-specific B cells, driving germinal center isotype switching to IgG, somatic hypermutation with affinity maturation, and generation of polysaccharide-specific memory B cells capable of mounting rapid anamnestic booster responses upon subsequent exposure from early infancy.
Downstream
-
Polysaccharide Capsule-Mediated Mucosal Colonization and Complement Evasion
High-affinity anti-capsular IgG antibodies target the bacterial polysaccharide capsule that mediates nasopharyngeal colonization and complement evasion
Show evidence (2 references)
"Plain polysaccharide vaccines fail to induce immunologic memory and also fail to elicit a booster response on repeated exposure"
Contrasts unconjugated polysaccharide vaccines, which fail to generate memory or booster responses, with glycoconjugate vaccines.
"Antibody responses to proteins are T cell dependent and can be elicited from a very young age, resulting in high-affinity antibodies with isotype switching, affinity maturation, and the generation of immunologic memory. Subsequent exposure to the antigen results in a significant booster response."
Details the T-cell-dependent germinal center cascade of isotype switching, affinity maturation, and immunologic memory elicited by protein-conjugated vaccines from infancy.
Anti-Capsular IgG Mucosal Carriage Reduction and Invasive Bacteremia Blockade
consequence
High-titer anti-capsular IgG antibodies neutralize the immune-evasive polysaccharide capsule of colonized bacteria via complement-mediated opsonophagocytosis and serum bactericidal activity, clearing or preventing nasopharyngeal colonization (generating population-level herd protection) and blocking mucosal invasion into the bloodstream and central nervous system.
Show evidence (2 references)
"Both are encapsulated bacteria with high nasopharyngeal carriage rates in children and adolescents, and their polysaccharide capsules facilitate immune evasion, promoting colonization, bloodstream invasion, and entry into the central nervous system by crossing the blood-brain barrier."
Establishes the conserved role of the polysaccharide capsule in nasopharyngeal colonization, immune evasion, bacteremia, and CNS invasion across Streptococcus pneumoniae and Neisseria meningitidis.
"Hib nasopharyngeal carriage is reduced in those who are vaccinated, thereby interrupting transmission of Hib to susceptible unvaccinated children and adults (i.e., herd protection)"
Demonstrates that glycoconjugate vaccination reduces nasopharyngeal carriage of encapsulated bacteria and interrupts community transmission.